BOSTON and SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

TOKYO -- As part of his first Asian tour in his second term, U.S. President Donald Trump visited Malaysia, Japan and South Korea. Of all the events he attended during the trip, the one that left the ...

Abstract: Rapport has been recognized as an important aspect of relationship building. While rapport in the context of human-human interaction has been widely studied, how it can be established and ...

BOSTON and SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and ...

Rapport Therapeutics, Inc.'s RAP-219 delivered impressive Phase 2a results in drug-resistant focal onset seizures, driving Rapport Therapeutics' stock up over 135% and boosting investor optimism. The ...

Shares of Rapport Therapeutics popped Monday morning after Phase IIa data for RAP-219 exceeded analyst and Wall Street expectations, reducing seizures by almost 78% in patients with drug-resistant ...

According to professional speaker, consultant and founder of Cause Matters Corp Michele Payn-Knoper, building rapport with customers is critical to showing them "you're sincerely interested in a ...

The FDA has placed a trial of Rapport Therapeutics’ epilepsy drug for a type of nerve pain on hold while the biotech tweaks the study design. Rapport has been evaluating the TARPγ8-targeting drug, ...

Language processing happens at speeds significantly faster than it takes to speak one word aloud. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.